#GoldenCross $AXDX at 14.70 R11 HiLo 58% T1Y 14 buy fwdPE -13.4 DIV N/A #Accelerate #stocks #trading #finance #market

2020-08-07
68 Views

Golden Cross detected for AXDX (Accelerate Diagnosti) at the close price of 14.70. Trading at a 58 % level between the 52week High (22.13) and 52week Low (4.53). The average analyst 1-year target price is 14.0 with an average buy and a score of 0.0.

Golden Cross
11 %
AXDX
14.70
Accelerate Diagnosti
HiLo
57.8 %
Support
13.96
Resistance
16.56
50DMA
13.53
200DMA
13.53
52week high
22.13
52week low
4.53
10DMA
14.96
20DMA
16.03
100 Mean
11.21
Volume
289651
AvgDayVol
474315
MarketCap
812477824
EBITDA
-69008000
Revenue
9889000
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index -63 Current 84.8 MA20 -8.16 Lower 124.92 Upper Bound #stocks #trading #markets #finance
Bull, Global Indicators
6 views
Bull, Global Indicators
6 views

HILO Index -63 Current 84.8 MA20 -8.16 Lower 124.92 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-09-22

[Bullish] HILO Index -63 Current 84.8 MA20 -8.16 Lower 124.92 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index -5.74 Avg 51.66 Std -1 Curr #stocks #trading #markets #finance
Global Indicators,
6 views
Global Indicators,
6 views

Demark B/S Index -5.74 Avg 51.66 Std -1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-09-22

Demark B/S Index -5.74 Avg 51.66 Std -1 Curr #stocks #trading #markets #finance

50/200 DMA Index 2.68 Avg 4.84 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
8 views
Global Indicators,
8 views

50/200 DMA Index 2.68 Avg 4.84 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-09-22

50/200 DMA Index 2.68 Avg 4.84 Std 1 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.